Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis

Early Access (Web of Science), Review Article (Web of Science)

• cited authors: Habboush, Shady; Kagita, Navyamani V.; Gadelmawla, Ahmed F.; Elmoursi, Ahmed; Merza, Nooraldin; Abdo, Ahmed A.; Zahran, Al Hussein M.; Eldeib, Moustafa; Almarghany, Alsayed A.; Abdelfadil, Mohamed M.; Abdelkarim, Mohamed A.; Shawky, Islam; Mohammed, Omar M.; Alharran, Abdullah; Ali, Mahmoud M.; Elbardisy, Shereef
• publication date: November 19, 2024
• webpage: Web of Science
• published in: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION Journal
• category: PERIPHERAL VASCULAR DISEASE Category

keywords

• Dyslipidemia
• Hypertension
• TAR
• Telmisartan/amlodipine/rosuvastatin
• Triple therapy